TechAccel

TechAccel is a venture capital firm that accelerates technology commercialization in agriculture, animal health, and food technology sectors. Founded in 2014, the firm sources, invests in, and acquires early-stage innovations, bridging the gap between discovery and commercialization. Through collaborations with universities and research institutions, TechAccel conducts science advancement and de-risking research to ready technologies for market.

The firm's investment strategy focuses on sectors such as agriculture, animal health, and food technology, targeting companies at various stages including seed, early stage, Series A, Series B, growth, and late stage. TechAccel's geographical focus is primarily within the United States, aiming to enhance food production and quality through technological innovation.

TechAccel's portfolio includes a range of companies and initiatives in the agriculture and animal health sectors. Notably, the firm operates subsidiaries like RNAissance Ag, which develops safe and effective biopesticides. The firm's leadership includes CEO Michael Helmstetter, who co-founded TechAccel in 2014, and Chairman Greg Graves, who brings extensive executive experience to the role. TechAccel's approach combines equity investment with research and development to advance transformative science in its focus areas.